Evaluation of antioxidant status in patients with primary hepatocellular carcinoma;Ocena statusu antyoksydacyjnego u chorych z pierwotnym rakiem wa̧troby

Polski Merkuriusz Lekarski

Volumn 15, Issue 86, 2003, Pages 118-122

  Czeczot, Hanna ^a   Skrzycki, Michał ^a   Gawryszewska, Ewelina ^a   Podsiad, Małgorzata ^a   Porembska, Zofia ^a  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Antioxidant status; Cancer; Catalase; Liver; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; CATALASE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; BLOOD; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYMOLOGY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; MALE; METABOLISM; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATALASE; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; SUPEROXIDE DISMUTASE;

EID: 0141537204     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Andrzejak R., Goch J.H., Jurga M.: Wolne rodniki i ich znaczenie w medycynie. Post. Hig. Med. Dośw., 1995, 49, 531-549.
2. Bartosz G. i wsp.: Simple determination of peroxyl radical - trapping capacity. Biochem. Mol. Biol. Int., 1998, 46, 519-528.
3. Beauchamp C., Fridovich K.: Superoxide dismutase: improved assays and assay applicable to acrylamide gels. Annal. Biochem., 1971, 99 (1), 276-281.
4. Bellisola G. i wsp.: Catalase activity in human hepatocellular carcinoma (HCC). Clin. Biochem., 1987, 20(6), 415-417.
5. Bradford M.M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein - dey binding. Anal. Biochem., 1976, 72, 248-254.
6. Casaril M.: Decreased activity of scavenger enzymes in human hepatocellular carcinoma, but not in liver metastases. Int. J. Clin. Lab. Res., 1994, 24(2), 94-97.
7. Cerrutii P. i wsp.: The role of the cellular antioxidant carcinogenesis. Environ. Health Perspect., 1994, 102, Suppl. 10, 123-129.
8. Chora̧ży M.: Molekularne aspekty kancerogenezy. Nowotwory, 1997, 47, 251-264.
9. Crapo J.D.: Copper, zinc superoxide dismutase is primarily a cytosolic protein in human cells. Proc. Natl. Acad. Sci., USA, 1992, 89, 10405-10409.
10. Fridovich I.: The biology of oxygen radicals. Science, 1978, 201(8), 875-880.
11. Géth L.: A simple method for determination of serum catalse and revision of reference range. Clinica Chimica Acta, 1991, 196, 143-152.
12. Gruber B.: Enzymy chronia̧ce organizm przed aktywnymi postaciami tlenu. Farm. Pol., 1996, 67, 11112, 750-756.
13. Halliwell B., Gutteridge J.M.C., Cross C.E.: Free radicals, antioxidants, and human disease: where are we now. J. Clin. Lab. Med., 1992, 119, 598-620.
14. Hassan H.M.: Biosynthesis and regulation of superoxide dismutases. Free Radic. Biol. Med., 1988, 5, 377-385.
15. Jacobs R.: The integrated antioxidant system. Nutr. Res., 1995, 15, 755-766.
16. Jaruga P., Oliński R.: Activity of antioxidant enzymes in cancer diseasese. Post. Hig. Med. Dośw., 1994, 48(4), 443-455.
17. Krawczyk M. (red).: Nowotwory przewodu pokarmowego. Wyd. Lek. PZWL, Warszawa 2001.
18. Liaw K.Y. i wsp.: Zinc, copper, and superoxide dismutase in hepatocellular carcinoma. Am. J. Gastroenterol., 1997, 92(12), 2260-2263.
19. Liczmański A.E.: Toksyczność tlenu. L Uszkodzenia żywych komórek. Post. Bioch., 1988, 34, 273-291.
20. Lin M.T. i wsp.: Superoxide dismutase in hepatocellular carcinoma affects patient prognosis. Hepatogastroenterol., 2001, 48(40), 1102-1105.
21. Litwin J.A. i wsp.: Immunocytochemical investigation of catalase and peroximal lipid beta-oxidation in human hepatocellular tumors and liver cirrhosis. Virchows Arch., 1999, 435(5), 486-495.
22. Mates J.M., Perez-Gomez C., Nunez de Castro I.: Antioxidant enzymes and human diseases. Clin. Biochem., 1999, 32(8), 595-603.
23. Oberley T.D., Oberley L.W.: Antioxidant enzyme levels in cancer. Histol. Histopathol., 1997, 12, 525-535.
24. Sun Y.: Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic. Biol. Med., 1990, 8(6), 583-599.
25. Sun Y., Oberley L.W.: Redox regulation of transcriptional activators. Free Radic. Biol. Med., 1996, 21, 335-348.
26. Van der Berg R. i wsp.: Transcriptional faktor NF-kappa B as a potential biomarker for oxidative stress. Br. J. Nutr., 2001, 86 (1), 121-127.
27. Vuillaume M.: Reduced oxygen species, mutation, induction and cancer initiation. Mutation Res., 1987, 186, 43-72.
28. Yu B.P.: Cellular defenses against damage from reactive oxygen species. Physiol. Rev., 1994, 74, 139-162.
29. Yamanoi A. i wsp.: Clinical and enzymatic investigation of induction of oxygen free radicals by ischemia and reperfusion in human hepatocellular carcinoma and adjacent liver. HPB Surg. 1995, 8(3), 193-199.
30. Zatońskí W. i wsp.: Atlas of Cancer Mortality in Central Europe, IARC Scientific Publications No. 134, Lyon 1996.